EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)Multizentrische Studie

A phase II randomized, double-blind, placebo-controlled study of Nuvastatic (C50SEW505OESA), a standardized rosmarinic acid-rich polymolecular botanical extract formulation to reduce cancer-related fatigue in patients with solid tumors

Mei Ling Ng, Amin Malik Shah Abdul Majid, Siew Mei Yee, V Natesan, Mohamed Khadeer Ahamed Basheer, Ashok Gnanasekaran, Fouad Saleih Resq Al-Suede, Christopher Parish, Meena Dalal, Long Chiau Ming, Mansoureh Nazari V, Shamsuddin Sultan Khan und 4 weitere

Supportive Care in Cancer · 2024-06 · 32 (6)

DOI: 10.1007/s00520-024-08536-w ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, online erschienen am 06.05.2024. Verfasst von Mei Ling Ng und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Fatigue, Neoplasms, Rosmarinic Acid, Depsides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: The Malaysian Ministry of Agriculture, Malaysia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FatigueNeoplasmsRosmarinic AcidDepsidesCinnamatesHumansDouble-Blind MethodFemaleMiddle AgedMaleAgedAdultPlant Extracts

Stichwörter der Autor:innen

C5OSEW5050ESACancer-related fatigueNuvastaticOrthosiphon stamineus

Substanzen

Rosmarinic AcidDepsidesCinnamatesPlant Extracts

Autor:innen und Institutionen

  • Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • EMAN Research Ltd, Symonston, Australia.
  • College of Health & Medicine, Australian National University, Canberra, Australia.
  • Faculty of Pharmacy, SEGi University, Petaling Jaya, Malaysia.
  • EMAN Biodiscoveries Sdn. Bhd, Sungai Petani, Malaysia.
  • Department of Pharmacology, Faculty of Medicine, Quest International University, Ipoh, Malaysia.

Förderung

  • The Malaysian Ministry of Agriculture, Malaysia

Zitieren

APA

Ng, M. L., Majid, A. M. S. A., Yee, S. M., Natesan, V., Basheer, M. K. A., Gnanasekaran, A., Al-Suede, F. S. R., Parish, C., Dalal, M., Ming, L. C., Nazari V, M., Khan, S. S., Stn Hameed Sultan, S. B., Babu, K. G., Majid, A. S. A., & Abdul Aziz, M. A. S. (2024). A phase II randomized, double-blind, placebo-controlled study of Nuvastatic (C50SEW505OESA), a standardized rosmarinic acid-rich polymolecular botanical extract formulation to reduce cancer-related fatigue in patients with solid tumors. Supportive Care in Cancer, 32(6). https://doi.org/10.1007/s00520-024-08536-w

Vancouver

Ng ML, Majid AMSA, Yee SM, Natesan V, Basheer MKA, Gnanasekaran A, et al. A phase II randomized, double-blind, placebo-controlled study of Nuvastatic (C50SEW505OESA), a standardized rosmarinic acid-rich polymolecular botanical extract formulation to reduce cancer-related fatigue in patients with solid tumors. Supportive Care in Cancer. 2024;32(6). doi:10.1007/s00520-024-08536-w

BibTeX
@article{Ng2024,
  author = {Ng, Mei Ling and Majid, Amin Malik Shah Abdul and Yee, Siew Mei and Natesan, V and Basheer, Mohamed Khadeer Ahamed and Gnanasekaran, Ashok and Al-Suede, Fouad Saleih Resq and Parish, Christopher and Dalal, Meena and Ming, Long Chiau and Nazari V, Mansoureh and Khan, Shamsuddin Sultan and Stn Hameed Sultan, Siti Balkees and Babu, K Govind and Majid, Aman Shah Abdul and Abdul Aziz, Mohamed Amir Shah},
  title = {A phase II randomized, double-blind, placebo-controlled study of Nuvastatic (C50SEW505OESA), a standardized rosmarinic acid-rich polymolecular botanical extract formulation to reduce cancer-related fatigue in patients with solid tumors},
  journal = {Supportive Care in Cancer},
  year = {2024},
  volume = {32},
  number = {6},
  doi = {10.1007/s00520-024-08536-w}
}
Kostenlos starten →